home / stock / avte / avte news


AVTE News and Press, Aerovate Therapeutics Inc. From 09/20/21

Stock Information

Company Name: Aerovate Therapeutics Inc.
Stock Symbol: AVTE
Market: NASDAQ
Website: aerovatetx.com

Menu

AVTE AVTE Quote AVTE Short AVTE News AVTE Articles AVTE Message Board
Get AVTE Alerts

News, Short Squeeze, Breakout and More Instantly...

AVTE - Aerovate Therapeutics Inc. Shares Sinking Lower, Down 29.6%

One of today's stocks on the move is Aerovate Therapeutics Inc. (NSD:AVTE), down 29.6% to $14.52. In the past 52 weeks, shares of Aerovate Therapeutics Inc. have traded between a low of $11.40 and a high of $29.43 and is now at $14.52, which is 27% above that low price. Receive IBN Spo...

AVTE - ATER, GREE and BEST among mid-day movers

Gainers: ZIVO Bioscience (NASDAQ:ZIVO) +98%. Edesa (NASDAQ:EDSA) +68%. Sentage (NASDAQ:SNTG) +21%. Viveve (NASDAQ:VIVE) +19%. Aterian (NASDAQ:ATER) +15%. Atea Pharmaceuticals (NASDAQ:AVIR) +12%. Corvus (NASDAQ:CRVS) +13%. Five Star (NASDAQ:FVE) +12%. BEST (NYSE:BEST) +10%. Petros Pharmaceutic...

AVTE - Aerovate Therapeutics Announces Its Addition to the Russell 2000® Index

WALTHAM, Mass., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, announced it has been added to the Rus...

AVTE - BELLUS Health, aTyr Pharma leads healthcare gainers; Virpax Pharmaceuticals, RedHill Biopharma among major losers

Gainers: BELLUS Health (NASDAQ:BLU) +26%, aTyr Pharma (NASDAQ:LIFE) +22%, Jounce Therapeutics (NASDAQ:JNCE) +14%, NanoViricides (NYSE:NNVC) +12%, Matinas BioPharma (NYSE:MTNB) +12%. Losers: Virpax Pharmaceuticals (NASDAQ:VRPX) -37%, RedHill Bi...

AVTE - Aerovate Therapeutics Announces Second Quarter 2021 Financial Results

WALTHAM, Mass. , Aug. 16, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced its financial results ...

AVTE - Wall Street Breakfast: The Week Ahead (Podcast)

You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)

AVTE - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Tech heavyweights will be in the spotlight next week with Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Alphabet (NASDAQ...

AVTE - Stocks To Watch: Apple And Tesla Lead Earnings Blitz, New IPOs And SPAC Debuts

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

AVTE - Aerovate Therapeutics Appoints Allison Dorval To Its Board of Directors

BOSTON, July 19, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the appointment of Allison Dorval, ...

AVTE - Last IPO Week Was The Busiest In Over a Decade

We have witnessed a record last week, with 19 launched IPOs and almost $10 billion raised. That is the most companies in one week since 2004. Even more, the NYSE floor which has been rather quiet in the past year came back to life. SPACs have been favored for a good part of 2020 and the beg...

Previous 10 Next 10